Tare da zaren COVID-19 daga ko'ina cikin duniya, kuma novel coronaviruses suna cikin nau'in β.COVID-19 cuta ce mai saurin kamuwa da numfashi.Mutane gabaɗaya suna da sauƙi.A halin yanzu, marasa lafiya da suka kamu da cutar sankara ta coronavirus sune babban tushen kamuwa da cuta;Mutanen da suka kamu da asymptomatic suma suna iya zama tushen kamuwa da cuta.Dangane da binciken cututtukan cututtuka na yanzu, lokacin shiryawa shine kwanaki 1 zuwa 14, galibi daga kwanaki 3 zuwa 7.Babban bayyanar cututtuka sun haɗa da zazzabi, gajiya da bushewar tari.Ana samun cunkoso na hanci, hanci mai gudu, ciwon makogwaro, myalgia da gudawa a cikin ƴan lokuta, don haka buƙatun na'urorin gwajin COVID-19 suna ƙara zama cikin gaggawa.Akwai da yawa na dillalai da ke sadaukar da COVID-19 a cikin kasuwa.
Koyaya, rahoton ya nuna cewa gano nucleic acid na yanzu (PCR) na sabon coronavirus zai iya tantance ko mutum ya kamu da cutar.Gwajin rigakafin cutar ana ɗaukarsa da mahimmanci a wurin masu ilimin cututtukan dabbobi saboda a karon farko za a yi kiyasin ainihin adadin mutanen da suka kamu da sabon coronavirus.Amma yana da matukar wahala a cimma daidaito 100%.
Don biyan buƙatu a kasuwannin duniya, sabon nau'in na'urorin gwajin COVID-19 an buga su cikin kasuwa ta hanyar likitancin Konsung.
Ka'idar aiki na Novel Coronavirus COVID-19 IgM/IgG Test Kit (Colloidal Zinariya) ya dogara ne akan ka'idar kama immunoassay don tantance ƙwayoyin rigakafi na SARS-CoV-2 IgG da IgM a cikin jinin ɗan adam gaba ɗaya, jini, plasma.Lokacin da aka ƙara samfurin a cikin na'urar gwaji, samfurin yana shiga cikin na'urar ta hanyar aikin capillary.Darajar hankali ya riga ya kai 91.54%, ƙimar ƙayyadaddun ƙayyadaddun ya riga ya kai 97.02%, kuma jimlar daidaituwar asibiti ta riga ta kai 95.09%.Babban daidaito na sakamakon gwaji ya jawo ƙarin abokin ciniki don siye a duniya.
Lokacin aikawa: Yuli-25-2020